June 4: The “Myelennial” Generation - Managing the Boom of Innovative Therapy to Transform Myeloma Care and Enhance Patient Outcomes

The HealthTree Foundation for Multiple Myeloma is proud to host a PEERView session at the upcoming ASCO conference with the topic The "Myelennial" Generation - Managing the Boom of Innovative Therapy to Transform Myeloma Care and Enhance Patient Outcomes. The session will feature myeloma experts Nina Shah, MD, Shaji Kumar, MD and Sagar Lonial, MD.

Register Live or Virtual

Date/Time

• Saturday, June 4
• 7:00 - 8:30 pm Central

Key Reasons to Attend

• Explore recent changes in therapy selection for newly diagnosed MM, including antibody and triplet therapy options, and guideline recommendations for upfront treatment of ASCT-ineligible and -eligible disease
• Hear the evidence that supports CD38 antibodies, XPO1 inhibitors, and BCMA-targeting options in RRMM
• Understand how to manage the unique AEs associated with BCMA ADCs, CAR-T therapy, and bispecific agents, such as keratopathy/ocular toxicity, CRS, ICANS, and peripheral neuropathy

This activity has been developed in partnership with HealthTree Foundation for Multiple Myeloma.

Meet Your Presenters

Chair & Presenter
Nina Shah, MD
UCSF Helen Diller Family Comprehensive Cancer Center
The University of California, San Francisco
San Francisco, California

Presenter
Shaji K. Kumar, MD
Mayo Clinic
Rochester, Minnesota

Presenter
Sagar Lonial, MD, FACP
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

The Live meeting will be Hyatt Regency Chicago, Grand Ballroom AB, Ballroom Level (East Tower), 151 East Wacker Drive, Chicago, Illinois 60601